Reviewed,
UniProtKB/Swiss-Prot P42702 (LIFR_HUMAN)
Last modified
November 25, 2008.
Version 84.
History...
Clusters with 100%,
90%,
50% identity |
Documents (8) |
Third-party data |
Customize display | text xml rdf/xml gff fasta |
Names and origin
| Protein names | Recommended name: Leukemia inhibitory factor receptor Short name=LIF receptor Short name=LIF-R Alternative name(s): CD_antigen=CD118 | ||
| Gene names |
| ||
| Organism | Homo sapiens (Human) | ||
| Taxonomic identifier | 9606 [NCBI] | ||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
Protein attributes
| Sequence length | 1097 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level. |
General annotation (Comments)
| Function | Signal-transducing molecule. May have a common pathway with IL6ST. The soluble form inhibits the biological activity of LIF by blocking its binding to receptors on target cells. |
| Subunit structure | Heterodimer composed of LIFR and IL6ST. |
| Subcellular location | Isoform 1: Cell membrane; Single-pass type I membrane protein. Isoform 2: Secreted. |
| Domain | The WSXWS motif appears to be necessary for proper protein folding and thereby efficient intracellular transport and cell-surface receptor binding. The box 1 motif is required for JAK interaction and/or activation. |
| Involvement in disease | Defects in LIFR are the cause of Stueve-Wiedemann syndrome (SWS) [MIM:601559]; also called Schwartz-Jampel syndrome type 2 or SJS2. SWS is a severe autosomal recessive condition and belongs to the group of the bent-bone dysplasias. SWS is characterized by bowing of the lower limbs, with internal cortical thickening, wide metaphyses with abnormal trabecular pattern, and camptodactyly. Additional features include feeding and swallowing difficulties, as well as respiratory distress and hyperthermic episodes, which cause death in the first months of life. The rare survivors develop progressive scoliosis, spontaneous fractures, bowing of the lower limbs, with prominent joints and dysautonomia symptoms, including temperature instability, absent corneal and patellar reflexes, and smooth tongue. A chromosomal rearrangement involving LIFR may be a cause of salivary gland pleiomorphic adenomas (PA) [181030]. Pleiomorphic adenomas are the most common benign epithelial tumors of the salivary gland. Translocation t(5;8)(p13;q12) with PLAG1. |
| Sequence similarities | Belongs to the type I cytokine receptor family. Type 2 subfamily. Contains 6 fibronectin type-III domains. |
Ontologies
Keywords | |
|---|---|
| Cellular component | Cell membrane Membrane Secreted |
| Coding sequence diversity | Alternative splicing Chromosomal rearrangement Polymorphism |
| Disease | Disease mutation |
| Domain | Repeat Signal Transmembrane |
| Molecular function | Receptor |
| PTM | Glycoprotein Phosphoprotein |
| Technical term | 3D-structure |
Gene Ontology (GO) | |
| Biological process | cytokine and chemokine mediated signaling pathway Inferred from direct assay. Source: MGI positive regulation of cell proliferationInferred from direct assay. Source: MGI |
| Cellular component | extracellular region Inferred from electronic annotation. Source: UniProtKB-KW integral to plasma membrane Ref.1Traceable author statement. Source: ProtInc |
| Molecular function | leukemia inhibitory factor receptor activity Ref.1 Inferred from direct assay. Source: MGI |
| Complete GO annotation... | |
Alternative products
| This entry describes 2 isoforms produced by alternative splicing. [Select] | ||||||
| Isoform 1 (identifier: P42702-1) Also known as: Membrane; This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform 2 (identifier: P42702-2) Also known as: Secreted; The sequence of this isoform is not available. | ||||||
| Notes: No experimental confirmation available. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||||
Molecule processing | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Signal peptide | 1 – 44 | 44 | Potential | ||||||||
| Chain | 45 – 1097 | 1053 | Leukemia inhibitory factor receptor | PRO_0000010902 | |||||||
Regions | |||||||||||
| Topological domain | 45 – 833 | 789 | Extracellular Potential | ||||||||
| Transmembrane | 834 – 858 | 25 | Potential | ||||||||
| Topological domain | 859 – 1097 | 239 | Cytoplasmic Potential | ||||||||
| Domain | 46 – 131 | 86 | Fibronectin type-III 1 | ||||||||
| Domain | 332 – 428 | 97 | Fibronectin type-III 2 | ||||||||
| Domain | 433 – 530 | 98 | Fibronectin type-III 3 | ||||||||
| Domain | 535 – 625 | 91 | Fibronectin type-III 4 | ||||||||
| Domain | 627 – 719 | 93 | Fibronectin type-III 5 | ||||||||
| Domain | 724 – 829 | 106 | Fibronectin type-III 6 | ||||||||
| Motif | 519 – 523 | 5 | WSXWS motif | ||||||||
| Motif | 869 – 877 | 9 | Box 1 motif | ||||||||
Amino acid modifications | |||||||||||
| Modified residue | 927 | 1 | Phosphoserine | ||||||||
| Glycosylation | 64 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 85 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 131 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 143 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 191 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 243 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 303 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 390 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 407 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 426 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 445 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 481 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 489 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 572 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 652 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 663 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 680 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 729 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 787 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Disulfide bond | 55 ↔ 65 | By similarity | |||||||||
| Disulfide bond | 82 ↔ 90 | By similarity | |||||||||
| Disulfide bond | 213 ↔ 270 | By similarity | |||||||||
| Disulfide bond | 341 ↔ 351 | By similarity | |||||||||
| Disulfide bond | 466 ↔ 511 | By similarity | |||||||||
Natural variations | |||||||||||
| Natural variant | 116 | 1 | H → Y: dbSNP rs3729734. | VAR_029109 | |||||||
| Natural variant | 279 | 1 | S → P in SWS. | VAR_025666 | |||||||
| Natural variant | 578 | 1 | D → N: dbSNP rs3729740. | VAR_029110 | |||||||
| Natural variant | 633 | 1 | I → M: dbSNP rs2303743. | VAR_021996 | |||||||
| Natural variant | 664 | 1 | S → L: dbSNP rs3729744. | VAR_038626 | |||||||
| Natural variant | 785 | 1 | V → I: dbSNP rs3110234. | VAR_029111 | |||||||
| Natural variant | 1068 | 1 | F → L in a colorectal cancer sample; somatic mutation. | VAR_036166 | |||||||
Sequences
| ||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Leukemia inhibitory factor receptor is structurally related to the IL-6 signal transducer, gp130." Gearing D.P., Thut C.J., Vanden Bos T., Gimpel S.D., Delaney P.B., King J., Price V., Cosman D., Beckmann M.P. EMBO J. 10:2839-2848(1991) [PubMed: 1915266] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1). Tissue: Placenta. |
| [2] | "Human LIF receptor 3' non-coding region." Wang Z., Melmed S. Submitted (AUG-1996) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 942-1097. |
| [3] | "The recurrent translocation t(5;8)(p13;q12) in pleomorphic adenomas results in upregulation of PLAG1 gene expression under control of the LIFR promoter." Voz M.L., Astrom A.-K., Kas K., Mark J., Stenman G., Van de Ven W.J.M. Oncogene 16:1409-1416(1998) [PubMed: 9525740] [Abstract] Cited for: CHROMOSOMAL TRANSLOCATION WITH PLAG1. |
| [4] | "A quantitative atlas of mitotic phosphorylation." Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P. Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed: 18669648] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-927, MASS SPECTROMETRY. |
| [5] | "Null leukemia inhibitory factor receptor (LIFR) mutations in Stueve-Wiedemann/Schwartz-Jampel type 2 syndrome." Dagoneau N., Scheffer D., Huber C., Al-Gazali L.I., Di Rocco M., Godard A., Martinovic J., Raas-Rothschild A., Sigaudy S., Unger S., Nicole S., Fontaine B., Taupin J.-L., Moreau J.-F., Superti-Furga A., Le Merrer M., Bonaventure J., Munnich A., Legeai-Mallet L., Cormier-Daire V. Am. J. Hum. Genet. 74:298-305(2004) [PubMed: 14740318] [Abstract] Cited for: VARIANT SWS PRO-279. |
| [6] | "The consensus coding sequences of human breast and colorectal cancers." Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D., Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S., Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J., Dawson D., Willson J.K.V. Velculescu V.E.Science 314:268-274(2006) [PubMed: 16959974] [Abstract] Cited for: VARIANT [LARGE SCALE ANALYSIS] LEU-1068. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| X61615 mRNA. Translation: CAA43805.1. U66563 mRNA. Translation: AAB61897.1. | |||||||||||||
| PIR | S17308. | ||||||||||||
| RefSeq | NP_001121143.1. NP_002301.1. | ||||||||||||
| UniGene | Hs.133421 | ||||||||||||
3D structure databases | |||||||||||||
| |||||||||||||
| ModBase | Search... | ||||||||||||
Protein-protein interaction databases | |||||||||||||
| DIP | DIP:5770N. | ||||||||||||
PTM databases | |||||||||||||
| PhosphoSite | P42702. | ||||||||||||
Genome annotation databases | |||||||||||||
| Ensembl | ENSG00000113594. Homo sapiens. [Contig view] | ||||||||||||
| GeneID | 3977. | ||||||||||||
| KEGG | hsa:3977. | ||||||||||||
Organism-specific databases | |||||||||||||
| H-InvDB | HIX0032117. | ||||||||||||
| HGNC | HGNC:6597. LIFR. | ||||||||||||
| HPA | CAB010252. | ||||||||||||
| MIM | 151443. gene. 601559. phenotype. | ||||||||||||
| Orphanet | 3206. Stuve-Wiedemann dysplasia. | ||||||||||||
| PharmGKB | PA30371. | ||||||||||||
| GenAtlas | Search... | ||||||||||||
| GeneCards | Search... | ||||||||||||
Phylogenomic databases | |||||||||||||
| HOGENOM | P42702. | ||||||||||||
| HOVERGEN | P42702. | ||||||||||||
Gene expression databases | |||||||||||||
| ArrayExpress | P42702. | ||||||||||||
| CleanEx | HS_LIFR. | ||||||||||||
| GermOnline | ENSG00000113594. Homo sapiens. | ||||||||||||
Family and domain databases | |||||||||||||
| InterPro | IPR008957. Fibronectin_typ-III-like_fold. IPR003961. FN_III. IPR003529. Hematopoietin_rcpt_gp130_CS. [Graphical view] | ||||||||||||
| Gene3D | G3DSA:2.60.40.30. FN_III-like. 2 hits. | ||||||||||||
| Pfam | PF00041. fn3. 2 hits. [Graphical view] | ||||||||||||
| SMART | SM00060. FN3. 5 hits. [Graphical view] | ||||||||||||
| PROSITE | PS50853. FN3. 6 hits. PS01353. HEMATOPO_REC_L_F2. 1 hit. [Graphical view] | ||||||||||||
| ProtoNet | Search... | ||||||||||||
Other Resources | |||||||||||||
| NextBio | 15588. | ||||||||||||
| SOURCE | Search... | ||||||||||||
Entry information
| Entry name | LIFR_HUMAN | ||||||||
| Accession | Primary (citable) accession number: P42702 Secondary accession number(s): Q6LCD9 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation project | HPI (Human Proteome Initiative) | ||||||||
Relevant documents
| Human cell differentiation molecules CD nomenclature of surface proteins of human leucocytes and list of entries |
| Human chromosome 5 Human chromosome 5: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| UniProtKB secondary accession numbers Index of UniProtKB secondary accession numbers |
| SIMILARITY comments Index of protein domains and families |

Clusters with


